HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hydrochlorothiazide in the metaphylaxis of recurrent calcium oxalate lithiasis].

Abstract
The main indication for the application of Disalunil in the convalescent care of recidive calcium-lithiasis patients is renal hypercalciuria. Treatment with 50 mg Disalunil/d reduced the rate of recidivation by two thirds. Even during long-term application of this therapy over 3-7 years, side effects were slight and did not require any cessation of therapy.
AuthorsC Bick, G Brien, D Fahlenkamp, R Koch
JournalZeitschrift fur Urologie und Nephrologie (Z Urol Nephrol) Vol. 75 Issue 11 Pg. 753-8 (Nov 1982) ISSN: 0044-3611 [Print] Germany
Vernacular TitleHydrochlorothiazide in der Metaphylaxe der rezidivierenden Kalzium-oxalatlithiasis.
PMID7164602 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hydrochlorothiazide
  • Calcium Oxalate
  • Potassium
Topics
  • Adult
  • Calcium Oxalate (urine)
  • Female
  • Humans
  • Hydrochlorothiazide (therapeutic use)
  • Male
  • Middle Aged
  • Potassium (blood)
  • Recurrence
  • Urinary Calculi (prevention & control, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: